SCHEMBL6173483

SCHEMBL6173483

CCCn1c(OC(=O)O)cc2cc([N+](=O)[O-])ccc21

nearest known ligand 0.47

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.45
CYP19A1 P11511 1/20 0.44
CCR2 P41597 2/20 0.44
CYP1A2 P05177 1/20 0.42
CNR2 P34972 1/20 0.42
MAPT P10636 4/20 0.41
MEN1 O00255 2/20 0.40
KDM4E B2RXH2 1/20 0.40
ALDH1A1 P00352 1/20 0.40
GAA P10253 1/20 0.40
LMNA P02545 1/20 0.40
BCL9 O00512 1/20 0.39
CTNNB1 P35222 1/20 0.39
CFTR P13569 1/20 0.39
GLS O94925 1/20 0.38
POLB P06746 1/20 0.38
ATM Q13315 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8131716 0.89 MAPT (0.50) KMT2ACYP19A1CCR2CYP1A2MAPT
SCHEMBL6172815 0.87 KMT2A (0.49) KMT2ACYP19A1CCR2CYP1A2CNR2
SCHEMBL6175680 0.85 EGFR (0.45) KMT2ACYP19A1CYP1A2CNR2MAPT
SCHEMBL6018883 0.81 CCR2 (0.61) KMT2ACYP19A1CCR2CYP1A2CNR2
SCHEMBL9241443 0.80 CCR2 (0.45) KMT2ACCR2MEN1LMNA
SCHEMBL7076382 0.79 CCR2 (0.51) KMT2ACCR2MAPTMEN1ALDH1A1
SCHEMBL6177863 0.78 CCR2 (0.43) KMT2ACYP19A1CCR2MAPTMEN1
SCHEMBL6174275 0.78 CCR2 (0.42) KMT2ACYP19A1CCR2MEN1
SCHEMBL7071931 0.78 CCR2 (0.72) CCR2
SCHEMBL5889460 0.77 MAPT (0.53) KMT2ACCR2MAPTMEN1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1432415-B1 SUBSTITUTED 2,5-DIAMIDOINDOLES AS ECE INHIBITORS FOR THE TREATMENT OF CARDIOVASCULAR DISEASES BAYER HEALTHCARE AG (DE) 2005-12-28 EP disclosed
EP-1432415-A1 SUBSTITUTED 2,5-DIAMIDOINDOLES AS ECE INHIBITORS FOR THE TREATMENT OF CARDIOVASCULAR DISEASES Bayer HealthCare AG (DE) 2004-06-30 EP disclosed
WO-2003028719-A1 SUBSTITUTED 2,5-DIAMIDOINDOLES AS ECE INHIBITORS FOR THE TREATMENT OF CARDIOVASCULAR DISEASES BAYER HEALTHCARE AG (DE) 2003-04-10 WO disclosed